Let's take a fresh look at the charts.
Let's check the charts and indicators.
The answer is plenty, but you can't trade that.
Let's check out the charts again so see how far this advance might carry.
Let's check some updated charts to see if our strategy is still on track.
Merck shares retreat as regulatory approval ramps up speculation.
There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.
Two companies, PepsiCo and Constellation Brands, are disrupting their own businesses and getting no credit whatsoever for doing so.
Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.
A fresh look is certainly warranted and perhaps overdue.